Why are some antiarrhythmic drugs proarrhythmic? Cardiac arrhythmia study by bifurcation analysis

被引:2
|
作者
Chay, TR
机构
[1] Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
关键词
bifurcation analysis; critical ring size; proarrhythmia by antriarrhythmic drugs; conduction velocity;
D O I
10.1016/S0022-0736(95)80055-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study employs a bifurcation analysis approach to elucidate the effect of the key ion channels on cardiac arrhythmias and thereby explain the efficacy of antiarrhythmic drugs in controlling arrhythmias. The model used for the analysis contains the key ion channels involved in the ventricular action potential-fast sodium, slow calcium, and background potassium channels. The cardiac tissue is modeled by a ring structure. The bifurcation diagram reveals that at a certain ring size, the amplitude of the action potential suddenly shrinks and the conduction velocity (CV) becomes unstable. Instability in CV leads to termination of reentrant arrhythmias. This ring size (ie, the critical ring size [CRS]) depends on the type of channel blocker. Blocking of the sodium channel leads to a decrease in the CRS, which in turn enhances stable reentry (proarrhythmia). Although calcium channel blockers do not alter the CV, they can exert the proarrhythmic effect by drastically shortening the CRS. The potassium channel blockers, on the other hand, are effective in controlling reentry in ventricular tissues by lengthening the CRS. Near blocking of the potassium channel, however, brings about another type of arrhythmia-the formation of ectopic foci. In the neighborhood of the CRS, the cycle length oscillates with an interesting pattern that depends on ring size and drug type. Although a critical reentrant loop length for stable reentrant excitation has been investigated for a long time, this study is the first demonstration of how the key ion channels in the plasma membrane affect the loop length. Furthermore, the analysis approach provides a theoretical basis for the increased mortality associated with class I drug use in the Cardiac Arrhythmia Suppression Trial Team.
引用
收藏
页码:191 / 197
页数:7
相关论文
共 50 条
  • [11] DIFFERENTIAL ANALYSIS OF THE FREQUENCY-DEPENDENT EFFECTS OF CLASS-1 ANTIARRHYTHMIC DRUGS ACCORDING TO PERIODICAL LIGAND-BINDING - IMPLICATIONS FOR ANTIARRHYTHMIC AND PROARRHYTHMIC EFFICACY
    WEIRICH, J
    ANTONI, H
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 (06) : 998 - 1009
  • [12] SOME ANALYSIS OF CARDIAC ARRHYTHMIA AND RESPIRATORY RATE IN RELATION TO PACING
    MANENICA, I
    ERGONOMICS, 1973, 16 (03) : 312 - 312
  • [13] ANTIARRHYTHMIC EFFECTS OF 2 NEW PROPAFENONE RELATED DRUGS - A STUDY ON 4 ANIMAL-MODELS OF ARRHYTHMIA
    WASCHER, TC
    DITTRICH, P
    KUKOVETZ, WR
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1991, 41-1 (02): : 119 - 124
  • [14] In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs
    Yoshiyuki Motokawa
    Yuji Nakamura
    Mihoko Hagiwara-Nagasawa
    Ai Goto
    Koki Chiba
    Nur Jaharat Lubna
    Hiroko Izumi-Nakaseko
    Kentaro Ando
    Atsuhiko T. Naito
    Hiroshi Yamazaki
    Atsushi Sugiyama
    Cardiovascular Toxicology, 2018, 18 : 242 - 251
  • [15] In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs
    Motokawa, Yoshiyuki
    Nakamura, Yuji
    Hagiwara-Nagasawa, Mihoko
    Goto, Ai
    Chiba, Koki
    Lubna, Nur Jaharat
    Izumi-Nakaseko, Hiroko
    Ando, Kentaro
    Naito, Atsuhiko T.
    Yamazaki, Hiroshi
    Sugiyama, Atsushi
    CARDIOVASCULAR TOXICOLOGY, 2018, 18 (03) : 242 - 251
  • [16] Ischemia-Related Subcellular Redistribution of Sodium Channels Enhances the Proarrhythmic Effect of Class I Antiarrhythmic Drugs: A Simulation Study
    Tsumoto, Kunichika
    Ashihara, Takashi
    Haraguchi, Ryo
    Nakazawa, Kazuo
    Kurachi, Yoshihisa
    PLOS ONE, 2014, 9 (10):
  • [17] APPARENT ARRHYTHMIA REDUCTION BY ANTIARRHYTHMIC THERAPY IN POSTINFARCTION PATIENTS - A NATURAL-HISTORY OF THE PLACEBO GROUP IN THE CARDIAC-ARRHYTHMIA PILOT-STUDY (CAPS)
    PRATT, CM
    HALLSTROM, AP
    COROMILAS, J
    ROMHILT, DW
    CIRCULATION, 1986, 74 (04) : 214 - 214
  • [18] A STUDY ON MECHANISM OF CARDIAC ARRHYTHMIAS - VERATRINE RESPONSE AND ANTIVERATRINIC ACTION AS A COMMON PROPERTY OF ANTIARRHYTHMIC DRUGS
    ARORA, RB
    SHARMA, PL
    GUPTA, VN
    LAL, A
    MATHUR, CN
    ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE, 1960, 124 (3-4): : 386 - 408
  • [19] Using human iPS cell models of cardiac arrhythmia to study cardiac calcium handling and to identify new drugs
    Yazawa, Masayuki
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 128 (03) : S69 - S69
  • [20] Theoretical study of cardiac transient conduction blocks on reentries induction. Applications to antiarrhythmic drugs
    Bardou, AL
    Auger, PM
    Chasse, JL
    Seigneuric, R
    ACTA BIOTHEORETICA, 1997, 45 (3-4) : 227 - 236